Physician profile
James Kratzer
NPI 1427167634
$1,416.22
in general payments reported to CMS, 2019-2025
18 companies · $83.97 in 2025
The $83.97 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $62.04 · 2021: $260 · 2022: $113 · 2023: $119 · 2024: $283 · 2025: $83.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $374.33 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $289.07 | 2019-2023 | |
| Cranial Technologies, INC | $133.19 | 2020-2024 | Doc Band |
| Hologic Sales and Service, LLC | $120.83 | 2019 | |
| Verrica Pharmaceuticals INC. | $104.89 | 2024-2025 | Ycanth |
| Kaleo, INC. | $84.46 | 2019-2022 | |
| Alk-Abello, INC | $63.19 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Collegium Pharmaceutical, INC. | $43.53 | 2025 | Jornay Pm |
| Tris Pharma INC | $42.75 | 2019 | |
| Seqirus USA INC | $39.95 | 2022-2024 | Flucelvax |
| Biofire Diagnostics, LLC | $33.87 | 2021 | |
| Glaxosmithkline, LLC. | $27.35 | 2019-2023 | Bexsero, Pediarix |
| Sobi, INC | $23.24 | 2019 | |
| Sanofi Pasteur INC. | $21.60 | 2022 | |
| Adlon Therapeutics L.P. | $13.97 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kratzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.